Rare extraintestinal manifestations of inflammatory bowel disease

Inflammatory Bowel Diseases

Volumn 10, Issue 2, 2004, Pages 140-147

  Hoffmann, R M ^a   Kruis, W ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Bullosa acquisita; Epidemiolysis; Extraintestinal manifestations; Inflammatory bowel disease; Sweet's syndrome

Indexed keywords

MESALAZINE; SALAZOSULFAPYRIDINE;

ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; ANEMIA; BONE NECROSIS; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; CROHN DISEASE; DEEP VEIN THROMBOSIS; ENTERITIS; EPIDERMOLYSIS BULLOSA ACQUISITA; ERYTHEMA NODOSUM; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG DISEASE; LUNG EMBOLISM; MULTIPLE SCLEROSIS; MYELODYSPLASTIC SYNDROME; MYOPATHY; NEPHROLITHIASIS; OBSTRUCTIVE UROPATHY; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PYODERMA GANGRENOSUM; RESPIRATORY TRACT DISEASE; REVIEW; SKIN DISEASE; SPINAL CORD DISEASE; URINARY TRACT FISTULA;

COMORBIDITY; EYE DISEASES; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; LUNG DISEASES, INTERSTITIAL; MALE; MUSCULOSKELETAL DISEASES; PREVALENCE; PROGNOSIS; RARE DISEASES; RISK ASSESSMENT; SKIN DISEASES;

EID: 1542619843     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/00054725-200403000-00013     Document Type: Review

References (134)

1. Farmer RG, Hawk WA, Turnbull RB Jr. Clinical patterns in Crohn's disease: A statistical study of 615 cases. Gastroenterology. 1975;68: 627-635.
2. Greenstein AJ, Janowitz HD, Sachar DB. The extra-intestinal complications of Crohn's disease and ulcerative colitis: A study of 700 patients. Medicine (Baltimore). 1976;55:401-412.
3. Monsen U, Sorstad J, Hellers G, et al. Extracolonic diagnoses in ulcerative colitis: An epidemiological study. Am J Gastroenterol. 1990;85: 711-716.
4. Rankin GB. Watts HD Melnyk CS, et al. National Cooperative Crohn's Disease Study: Extraintestinal manifestations and perianal complications. Gastroenterology. 1979;77:914-920.
5. Veloso FT, Carvalho J, Magro F. Immune-related systemic manifestations of inflammatory bowel disease: A prospective study of 792 patients. J Clin Gastroenterol. 1996;23:29-34.
6. Mir-Madjlessi SH, Taylor JS, Farmer RG. Clinical course and evolution of erythema nodosum and pyoderma gangrenosum in chronic ulcerative colitis: A study of 42 patients. Am J Gastroenterol. 1985;80:615-620.
7. Lee FI, Bellary SV, Francis C. Increased occurrence of psoriasis in patients with Crohn's disease and their relatives. Am J Gastroenterol. 1990;85:962-963.
8. Yates VM, Watkinson G, Kelman A. Further evidence for an association between psoriasis, Crohn's disease and ulcerative colitis. Br J Dermatol. 1982;105:323-330.
9. Kemmett D, Hunter JAA. Sweet's syndrome: A clinicopathologic review of twenty-nine cases. J Am Acad Dermatol. 1990;23:503-507.
10. Banet DE, Callen JP. Oral metronidazole, an effective treatment for Sweet's syndrome in a patient with associated inflammatory bowel disease. J Rheumatol. 1994;21:1766-1768.
11. Benton EC, Rutherford D, Hunter JAA. Sweet's Syndrome and Pyoderma gangrenosum Associated with Ulcerative Colitis. Acta Derm Venereol. 1985;65:77-80.
12. Kemmett D, Hunter JAA. Sweet's syndrome: A clinicopathologic review of twenty-nine cases. J Am Acad Dermatol. 1990;23:503-507.
13. Van't Veen AJ. Heule F, Vuzevski VD, den Hengst CW. Epidermolysis bullosa acquisita. Br J Dermatol. 1994;131:724-725.
14. Chen M, O'Toole EA, Sanghave J, et al. The epidermolysis bullosa acquisita antigen (type VII collagen) is present in human colon and patients with crohn disease have antoantibodies to type VII collagen. J Invest Dermatol. 2002;118:1059-1064.
15. Schattenkirchner S, Lemann M, Prost C, Caux F, Guigui B, Cadot M, Bertheau P, Grateau C, Heller M. Localized epidermolysis bullosa acquisita of the esophagus in a patient with Crohn's disease. Am J Gastroenterol. 1996 Aug;91(8):1657-1659.
16. Zimmer KP, Schumann H, Mecklenbeck S, et al. Esophageal stenosis in childhood: dystrophic epidermolysis bullosa without skin blistering due to collagen VII mutations. Gastroenterology. 2002;122:220-225.
17. Guest GD, Fink RLW. Metastatic Crohn's disease: case report of an unusual variant and review of the literature. Dis Colon Rectum. 2000;43: 1764-1766.
18. Hackzell-Bradley M, Hedblad M-A, Stephansson EA. Metastatic Crohn's Disease. Report of 3 Cases With Special Reference to Histopathologic Findings. Arch Dermatol. 1996;132:928-932.
19. Kim N-I, Eom J-Y, Sim W-Y, et al. Cohn's disease of the vulva. J Am Acad Dermatol. 1992;27:764-765.
20. Chiba M, Iizuka M, Horie Y, et al. Metastatic Crohn's disease involving the penis. J Gastroenterol. 1997;32:817-821.
21. McCallum DI, Gray WM. Metastatic Crohn's disease. Br J Dermatol. 1976;95:551-554.
22. Chen W, Blume-Peytavi U, Goerdt S, et al. Metastatic Crohn's disease of the face. J Am Acad Dermatol. 1996;35:986-988.
23. Shum D, Guenther L. Metastatic Crohn's disease: case report and review of the literature. Arch Dermatol. 1990;125:645-648.
24. Kafity AA, Pellegrini AE, Fromkes JJ. Metastatic Crohn's Disease. A rare cutaneous manifestation. J Clin Gastroenterol. 1993;17:300-303.
25. Peltz S, Vestey JP, Ferguson A, et al. Disseminated metastatic cutaneous Crohn's disease. Clin Exp Dermatol. 1993;18:55-59.
26. Marotta PJ, Reynolds RP. Metastatic Crohn's disease. Am J Gastroenterol. 1996;91:373-375.
27. McLelland J, Griffin SM. Metastatic Crohn's Disease of the umbilicus. Clin Exp Dermatol. 1996;21:318-319.
28. Chiba M, Izuka M, Horie Y, et al. Metastatic Crohn's disease involving the penis. J Gastroenterol. 1997;32:817-821.
29. Williams N, Scott NA, Watson JS, et al. Surgical management of perineal and metastatic cutaneous Crohn's disease. Br J Surg. 1993;80: 1596-1598.
30. Van Dullemen H, de Jong E, Slors F, et al. van Deventer, SJH. Treatment of Therapy-Resistant Perineal Metastatic Crohn's Disease After Proctectomy Using Anti-Tumor Necrosis Factor Chimeric Monoclonal Antibody, cA2: Report of Two Cases. Dis Colon Retum. 1998;41:98-102.
31. Boberg KM, Brinch L, Vatn M. Crohn Disease and the Myelodysplastic Syndrome. Ann Intern Med. 1995;122:395.
32. Castellote J, Porta F, Tuset E, et al. Crohn's Disease and the Myelodysplastic Sindrome. J Clin Gastroenterol. 1997;24:286-293.
33. Sahay R, Prangnell DR, Scott BB. Inflammatory bowel disease and refractory anaemia (myelodysplasia). Gut. 1993;34:1630-1631.
34. Harewood GC, Loftus EV Jr, Tefferi A, et al. Concurrent Inflammatory Bowel Disease and Myelodysplastic Syndromes. Inflamm Bowel Dis. 1999;5:98-103.
35. Hebbar M, Kozlowski D, Wattel E, et al. Association between myelodysplastic syndromes and inflammatory bowel diseases. Report of seven new cases and review of the literature. Leukemia. 1997;11:2188-2191.
36. Eng C, Farraye FA, Shulman LN, et al. The association between the myelodysplastic syndromes and Crohn's disease. Ann Int Med. 1992; 117:661-662.
37. Hamblin TJ. Immunologic abnormalities in myelodysplastic syndromes. Semin Hematol. 1996;33:150-162.
38. Reimund JM, Wittersheim C, Dumont S. Muller Crohn's disease, Kenney JS, Baumann R, Poindron P, Duclos B. Increased production of tumor necrosis factor-α, interleukin-1 β, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn's diseas. Gut. 1996;39:684-689.
39. Podolski DK. Inflammatory bowel disease. New Engl J Med. 1991;325: 1008-1016.
40. Enright H, Miller W. Autoimmune phenomena in patients with myelodysplastic syndromes. Leuk Lymphoma. 1997;24:483-489.
41. Hamblin TJ. Immunologic abnormalities in myelodysplastic syndromes. Leuk Lymphoma. 1997;24:483-489.
42. Wakefield AJ, Sankey EA, Dhillon AP, et al. Granulomatous vasculitis in Crohn's diseas. Gastroenterology. 1991;100:279-287.
43. Munch H, Purrmann J, Reis HE, et al. Clinical features of inflammatory joint and spine manifestations in Crohn's disease. Hepatogastroenterology. 1986;33:123-127.
44. Compston JE, Judd D, Crawley EO, et al. Osteoporosis in patients with inflammatory bowel disease. Gut 1987;28-410-5.
45. Hessov I, Mosekilde L, Melsen F, et al. Osteopenia with normal vitamin D metabolites after small-bowel resection for Crohn's disease. Scand J Gastroenterol. 1984;19:691-696.
46. Motley RJ, Clements D, Evans WD, et al. A four-year longitudinal study of bone loss in patients with inflammatory bowel disease. Bone Miner. 1993;23:95-104.
47. Pigot F, Roux C, Chaussade S, et al. Low bone mineral density in patients with inflammatory bowel disease. Dig Dis Sci. 1992;37:1396-1403.
48. Mankin HJ. Nontraumatic necrosis of bone (osteonecrosis). N Engl J Med. 1992;326:1473-1479.
49. Freeman HJ, Freeman KJ. Prevalence rates and estimation of reported risk factors for osteonecrosis (avascular necrosis) in Crohńs disease. Can J Gastroenterol. 2000;14:138-143.
50. Freeman HJ, Kwan WCP. Non-corticosteroid associated osteonecrosis of the femoral heads in two patients with inflammatory bowel disease. N Engl J Med 1993; 329:1314-1326.
51. Vakil N, Sparberg M. Seroid-related osteonecrosis in Inflammatory Bowel Disease. Gastroenterology. 1989;96:62-67.
52. Shapiro SC, Rothstein FC, Newman AJ, et al. Multifocal osteonecrosis in adolescents with Crohn's disease: a complication of therapy? J Pediatr Gastroenterol Nutr. 1985;4:502-506.
53. Zizic TM, Marcoux C, Hungerford DS, et al. Corticosteroid therapy associated with ischemic necrosis of bone in systemic lupus erythematosus. Am J Med. 1985;79:596-603.
54. Meyers MH. Osteonecrosis of the femoral head. Pathogenesis and long term treatment. Clin Orthop. 1988;231:51-61.
55. Abeles M. Urman jd; Rothfield N. Aseptic necrosis of bone in systemic lupus erythematosis: relationship to corticosteroid therapy. Arch Intern Med. 1978;138:750-754.
56. Bergstein JM, Wiens P, Fish AJ, et al. Avascular necrosis of bone in systemic lupus erythematosus. J Pediatr. 1974;85:31-35.
57. Dimant J, Ginzler E, Diamond H, et al. Computer analysis of factors influencing the appearance of aseptic necrosis in patients with SLE. J Rheumatol. 1978;5:136-141.
58. Wang G, Moga DB, Richemer WG, et al. Cortisone induced bone changes and its response to lipid clearing agents. Clin Orthop. 1978;130: 81-84.
59. Jones JP, Engleman EP, Najarian JS. Systemic fat embolism after renal homotransplantations and treatment with corticosteroids. N Engl J Med. 1965;273:1453-1455.
60. Kenzora JE, Glimcher MD. Accumulative cell stress: the multifactorial ehiology of idiopathic osteonecrosis. Orthop Clin North Am. 1985;16: 669-679.
61. Kenzora JE. Treatment of idiopathic osteonecrosis: the current philosophy and rationale. Orthop Clin North Am. 1985;16:717-725.
62. Banner MP. Genitourinary complications of inflammatory bowel disease. Radiol Clin North Am. 1987;25:199-209.
63. Greenstein AJ, Sachar DB, Panday AKN, et al. Amyloidosis and Inflammatory Bowel Disease: A 50-Year Experience with 25 Patients. Medicine (Baltimore). 1992;71:261-270.
64. Wester AL, Vatn MH, Fausa O. Secondary Amyloidosis in Inflammatory Bowel Disease: A Study of 18 Patients Admitted to Rikshospitalet University Hospital, Oslo, from 1962 to 1998. Inflamm Bowel Dis. 2001; 7:295-300.
65. Lovat LB, Madhoo S, Pepys MB, et al. Long-term survival in systemic amyloid A amyloidosis complicating Crohn's disease. Gastroenterology. 1997;112:1362-1365.
66. Meyers S, Janowitz HD, Gumaste VV, et al. Colchicine therapy of the renal amyloidosis of ulcerative colitis. Gastroenterology. 1988;94: 1503-1507.
67. Lossos. River Y, Eliakim A, and Steiner I. Neurologic aspects of inflammatory bowel disease. Neurology. 1995;45:416-421.
68. de la Fuente-Fernandez R, Rubio-Nazabal E, de la Iglesia-Martinez F. Guillain-Barré sindrome as an extraintestinal manifestation of Crohn's disease. Postgrad Med J. 1995;71:437-438.
69. Zimmermann J, Steiner I, Gavish D, et al. Guillain-Barré syndrome: a possible extraintestinal manifestation of ulcerative colitis. J Cin Gastroenterol. 1985;7:301-303.
70. Humbert P, Monnier G, Billerey C, et al. Polyneuropathy: an unusual extraintestinal manifestation of Crohn's disease. Acta Neurol Scand. 1989;80:301-306.
71. Moormann B, Herath H, Mann O, et al. Beteiligung des peripheren Nervensystems bei Morbus Crohn. Nervenarzt. 1999;70:1107-1111.
72. Nemni R, Fazio R, Corbo M, et al. Peripheral neuropathy associated with Crohn's disease. Neurology. 1987;37:1414-1417.
73. Okiyama R, Yamada M, Tamaki M, et al. Mononeuropathy Multiplex with Ulcerative Colitis. Intern Med. 1993;32:651-654.
74. Duffy LF, Daum F, Fisher SE, et al. Peripheral Neuropathy in Crohn's Disease Patients Treated With Metronidazole. Gastroenterology. 1985; 88:681-684.
75. Karlsson IJ, Hamlyn AN. Metronidazole neuropathy. Br Med J. 1977;3: 832.
76. Leibowith G, Eliakim R, Amir G, et al. Dermatomyositis associated with Crohn's disease. J Clin Gastroenterol. 1994;18:48-52.
77. Gilliam JH III, Challa VR, Agudelo CA, et al. Vasculitis involving muscle associated with Crohn's disease. Gastroenterology. 1981;81: 787-790.
78. Hall MJ, Thomas WEG, Cooper BT. Gastrocnemias myositis in a patient with inflammatory bowel disease. Digestion. 1985;32:296-300.
79. Menard DB, Haddad H, Blain JG, et al. Granulomatous myositis and myopathy associated with Crohn's disease. N Engl J Med. 1976;295: 818-819.
80. Kaneoka H, Iyadomi I, Hiida M, et al. An overlapping case of ulcerative colitis and polymyositis. J Rheumatol. 1990;17:274-276.
81. Chugh S, Dilawari JB, Sawhney IMS, et al. Plymyositis associated with ulcerative colitis. Gut. 1993;34:567-569.
82. Bhigjee AI, Bill PLA, Cosnett JE. Ulcerative colitis and interstitial myositis. Clin Neurol Neurosurg. 1987;89:261-263.
83. Elsebety AE, Bertorini TE. Neurological complications in Crohn's disease. Ann Neurol. 1991;30:271.
84. Talbot RW, Heppell J, Dozois RA, et al. Vascular complications of inflammatory bowel disease. Mayo Clin Proc. 1986;61:140-145.
85. Schapira M, Henrion J, Ravoet C, et al. Thromboembolism in inflammatory bowel disease. Acta Gastroenterol Belg. 1999;62:182-186.
86. Markowitz RL, Ment LR, Gryboski JD. Cerebral thromboembolic disease in pediatric and adult inflammatory bowel disease: case report and review of the literature. J Pediatr Gastroenterol Nutr. 1989;8:413-420.
87. Musio F, Older SA, Jenkins T, et al. Case report: cerebral venous thrombosis as a manifestation of acute ulcerative colitis. Am J Med Sci. 1993; 305:28-35.
88. García-Moncó JC, Bldarrain MG. Superior sagittal sinus thrombosis complicating Crohn's disease. Neurology. 1991;41:1324-1325.
89. Johns DR. Cerebrovascular complications of inflammatory colon disease. Am J Gastroenterol. 1991;86:367-370.
90. Adamek J, Wegener M, Wedmann B, et al. Zerebrale Vaskulitis bei Morbus Crohn. Leber Magen Darm. 1993;13:91-93.
91. Nelson J, Barron M, Riggs JE, et al. Cerebral vasculitis and ulcerative colitis. Neurology. 1986;36:719-721.
92. Geissler A, Andus T, Roth M, et al. Focal white-matter lesions in brain of patients with inflammatory bowel disease. Lancet. 1995;345:897-898.
93. Dejaco C, Fertl E, Prayer D, et al. Symptomatic Cerebral Microangiopathy Preceding Initial Manifestation of Ulcerative Colitis. Dig Dis Sci. 1996;41:1807-1810.
94. Gibb WRG, Dhillon DP, Zilkha KJ, et al. Bronchiectasis with ulcerative colitis and myelopathy. Thorax. 1987;42:155-156.
95. Ray DW, Bridger J, Hawnaur J, et al. Transverse myelitis as the presentation of JO-1 antibody syndrome (myositis and fibrosing alveolitis) in long-standing ulcerative colitis. Br J Rheumatol. 1993;32:1105-1108.
96. Cooke WT. Neurologic manifestations of malabsorption. In: Vinken PJ, Bruyn GW, eds. Handbook of clinical neurology, vol 28, part 2. Amsterdam: North-Holland, 1976:225-241.
97. Gold R, Kappos L, Becker T. Development of multiple sclerosis in patient on long-term sulfasalazine. Lancet. 1990;335:409-410.
98. Hefter H, Piontek M, Aulich A. Bacterial meningitis and dorsal spinal epidural abscess caused by Crohn's disease. Neurology. 1991;41:606-608.
99. Purrmann J, Arendt G, Cleveland S, et al. Association of Crohn's Disease and Multiple Sclerosis. J Clin Gastroenterol. 1992;14:43-46.
100. Kitchin LI, Knobler RL, Friedman LS. Crohn's Disease in a Patient with Multiple Sclerosis. J Clin Gastroenterol. 1991;13:331-334.
101. Rang EH, Brooke BN, Hermon-Taylor J. Association of ulcerative colitis with multiple sclerosis (letter). Lancet. 1982;2:555.
102. Minuk GY, Lewkonia RM. Possible Familial Association of Multiple Sclerosis and Inflammatory Bowel Disease. N Engl J Med. 1986;314: 586.
103. Sadovnick AD, Paty DW, Yannakoulias G. Concurrence of Multiple Sclerosis and Inflammatory Bowel Disease. N Engl J Med. 1989;321: 762-763.
104. Kimura K, Hunter SF, Thollander MS, et al. Concurrence of Inflammatory Bowel Disease and Multiple Sclerosis. Mayo Clin Proc. 2000;75: 802-806.
105. Agranoff D, Schon F. Are focal white matter lesions in patients with inflammatory bowel disease linked to multiple sclerosis? Lancet. 1995; 346:190-191.
106. Herrlinger KR, Noftz MK, Dalhoff K, et al. Alterations in pulmonary function in Inflammatory Bowel Disease are frequent and persist during remission. Am J Gastroenterol. 2002;97:377-381.
107. Marvisi M, Borrello PD, Brianti M, et al. Changes in the carbon monoxide diffusing capacity of the lung in ulcerative colitis. Eur Respir J. 2000; 16:965-968.
108. Kuzela L, Vavrecka A, Prikazska M, et al. Pulmonary complications in patients with Inflammatory Bowel Disease. Hepatogastroenterology. 1999;46:1714-1719.
109. Godet PG, Cowie R, Woodman RC, et al. Pulmonary Function Abnormalities in Patients with Ulcerative Colitis. Am J Gastroenterol. 1997; 92:7.
110. Tzanakis N, Samiou M, Bouros D, et al. Small airways function in patients with inflammatory bowel disease. Am J Respir Crit Care Med. 1998;157:382-386.
111. Johnson NM, Mee AS, Jewell DP, et al. Pulmonary function in inflammatory bowel disease. Digestion. 1978;18:416-418.
112. Tzanakis N, Bouros D, Samiou M, et al. Lung function in patients with inflammatory bowel disease. Respir Med. 1998;92:516-522.
113. Camus P, Piard F, Ashcroft T, et al. The lung in Inflammatory Bowel Disease. Medicine (Baltimore). 1993;72:151-183.
114. Spira A, Grossman R. and Meyer Balter. Large Airway Disease Associated With Inflammatory Bowel Disease. Chest. 1998;113:1723-1726.
115. Higenbottam T, Cochrane GM, Clark TH, et al. Bronchial disease in ulcerative colitis. Thorax. 1980;35:581-585.
116. Kraft SC, Earle RH, Roesler M, Esterly JR. Unexplained bronchopulmonary disease with inflammatory bowel disease. Arch Intern Med 1976; 454-59.
117. Kinnear W, Higenbottam T. Pulmonary manifestations of inflammatory bowel disease. IM. 1983;4:104-111.
118. Moles KW, Varghese G, Hayes JR. Pulmonary involvement in ulcerative colitis. Br J Dis Chest. 1988;82:79-83.
119. Wilcox P, Miller I, Miller G, et al. Airway involvement in ulcerative colitis. Chest. 1987;92:18-22.
120. Lemann M, Messing B, Agay F, et al. Crohńs disease with respiratory tract involvement. Gut. 1987;28:1669-1672.
121. Vendenplas O, Casel S, Delos M, et al. Granulomatous bronchiolitis associated with Crohńs disease. Am J Respir Crit Care Med. 1998;158: 1676-1679.
122. Gschwantler M, Kogelbauer G, Klose W, et al. The Pancreas as a Site of Granulomatous Inflammation in Crohn's Disease. Gastroenterology. 1995;108:1246-1249.
123. de Vries N, Gans ROB, Donker AJM, et al. Autoantibodies ageinst constituents of neutrophils in the diagnosis and treatment of (isolated) subglottic stenosis. Arch Otolaryngol Head Neck Surg. 1992;118:1120-1123.
124. Forrest JAH, Shearman DJC. Pulmonary vasculitis and ulcerative colitis. Am J Did Dis. 1975;20:482-485.
125. McCulloch AJ, McEvoy A, Jackson JD, et al. Severe steroid responsive pneumonitis associated with pyoderma gangrenosum and ulcerative colitis. Thorax. 1985;40:313-314.
126. Swinburn CR, Jackson GJ, Cobden I, et al. Bronchiolitis obliterans organizing pneumonia in a patient with ulcerative colitis. Thorax. 1988; 43:735-736.
127. Parry SD, Barbatzas C, Peel ET, et al. Sulfasalazine and lung toxicity. Eur Respir J. 2002;19:756-764.
128. Baillie J. Sulfasalazine and pulmonary infiltrates. Am J Gastroenterol. 1984;79:77.
129. Leino R, Lippo K, Ekfors T. Sulphasalazine-induced reversible hypersensitivity pneumonitis and fatal fibrosing alveolitis: Report of two cases. J Intern Med. 1991;229:553-556.
130. Tanigawa K, Sugiyama K, Matsuyama H, et al. Mesalazine-induced eosinophilic pneumonia. Respiration. 1999;66:69-72.
131. Saltzman K, Rossoff LJ, Gouda H, Tongia S. Mesalamine-induced unilateral eosinophilic pneumonia. Am J Roentgenol. 2001 Jul;177(1):257.
132. Bitton A, Peppercorn MA, Hanrahan JP, et al. Mesalamine-induced lung toxicity. Am J Gastroenterol. 1996;91:1039-1040.
133. Sviri S, Gafanovich I, Kramer MR, et al. Mesalamine-induced hypersensitivity pneumonitis. A case report and review of the literature. J Clin Gastroenterol. 1997;24:34-36.
134. Welte T, Hamm H, Fabel H. Meslazine alveolitis. Lancet. 1991;338: 1273.